Hypera SA (HYPMY)
OTHER OTC:HYPMY
Holding HYPMY?
Track your performance easily

Hypera SA (HYPMY) Stock Price & Analysis

7 Followers

HYPMY Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%0.03%99.97%
Insiders
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors

HYPMY FAQ

What was Hypera SA’s price range in the past 12 months?
Hypera SA lowest stock price was $3.55 and its highest was $7.50 in the past 12 months.
    What is Hypera SA’s market cap?
    Currently, no data Available
    When is Hypera SA’s upcoming earnings report date?
    Hypera SA’s upcoming earnings report date is Feb 20, 2025 which is in 96 days.
      How were Hypera SA’s earnings last quarter?
      Currently, no data Available
      Is Hypera SA overvalued?
      According to Wall Street analysts Hypera SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Hypera SA pay dividends?
        Hypera SA pays a Quarterly dividend of $0.02 which represents an annual dividend yield of 3.33%. See more information on Hypera SA dividends here
          What is Hypera SA’s EPS estimate?
          Hypera SA’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hypera SA have?
          Hypera SA has 633,420,840 shares outstanding.
            What happened to Hypera SA’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Hypera SA?
            Among the largest hedge funds holding Hypera SA’s share is Fisher Asset Management LLC. It holds Hypera SA’s shares valued at N/A.
              ---

              Hypera SA Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -46.78%
              12-Months-Change

              Fundamentals

              Return on Equity
              15.20%
              Trailing 12-Months
              Asset Growth
              -6.10%
              Trailing 12-Months

              Company Description

              Hypera SA

              Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the major pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure.
              ---

              HYPMY Company Deck

              ---

              HYPMY Earnings Call

              Q3 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Dr Reddy's Laboratories
              Takeda Pharmaceutical Company
              Protalix
              Axsome Therapeutics
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis